Clinical improvement in psoriasis with specific targeting of interleukin-23
Clinical improvement in psoriasis with specific targeting of interleukin-23
About this item
Full title
Author / Creator
Kopp, Tamara , Riedl, Elisabeth , Bangert, Christine , Bowman, Edward P. , Greisenegger, Elli , Horowitz, Ann , Kittler, Harald , Blumenschein, Wendy M. , McClanahan, Terrill K. , Marbury, Thomas , Zachariae, Claus , Xu, Danlin , Hou, Xiaoli Shirley , Mehta, Anish , Zandvliet, Anthe S. , Montgomery, Diana , van Aarle, Frank and Khalilieh, Sauzanne
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
A proof-of-concept phase I clinical trial demonstrates that targeting interleukin (IL)-23 with an antibody that binds to the p19 subunit leads to clinical improvement of disease in patients with moderate to severe psoriasis.
Antibody treatment of psoriasis
Sauzanne Khalilieh and colleagues report a proof-of-concept phase I clinical trial whic...
Alternative Titles
Full title
Clinical improvement in psoriasis with specific targeting of interleukin-23
Authors, Artists and Contributors
Author / Creator
Riedl, Elisabeth
Bangert, Christine
Bowman, Edward P.
Greisenegger, Elli
Horowitz, Ann
Kittler, Harald
Blumenschein, Wendy M.
McClanahan, Terrill K.
Marbury, Thomas
Zachariae, Claus
Xu, Danlin
Hou, Xiaoli Shirley
Mehta, Anish
Zandvliet, Anthe S.
Montgomery, Diana
van Aarle, Frank
Khalilieh, Sauzanne
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1681261841
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1681261841
Other Identifiers
ISSN
0028-0836
E-ISSN
1476-4687
DOI
10.1038/nature14175
